Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2025-12-24 @ 3:04 PM
NCT ID:
NCT07292259
Eligibility Criteria:
Inclusion Criteria:
• Patients suffering from Transfusion Dependent β-thalassemia (TDBT) more than two years of age of either sex will be included in the study.
Exclusion Criteria:
* Age less than two years.
* Patients having cardiac, hepatic, pulmonary, renal or neurological dysfunction or history of thrombosis.
* Both male and female participants of childbearing potential will be excluded due to the teratogenicity of thalidomide.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
12 Years
Study:
NCT07292259
Study Brief:
Protocol Section:
NCT07292259